TABLE 3.
Original tumor sources | Species source | Cell sources | Culture system | Applications | Limitations | References |
---|---|---|---|---|---|---|
CRC | Human | CRLM samples | Matrigel | Patient-specific anticancer drug screening | Incomplete recapitulation of CRLM phenotypes | 97 |
CRC and GOC | Human | Liver metastases from CRC and GOC | Matrigel | Anticancer drug sensitivity testing | Restrained experimental scale | 98 |
CRC | Human | CRLM samples | Matrigel | Drug screening; Individualized treatment |
Lack of coclinical trails | 99 |
Rectal cancer | Human | Surgically resected initial and recurrent liver metastases from rectal cancer | Matrigel | Spatio-temporal pharmacogenomic analysis; Drug screening |
Inconsistent drug response of PDOs and liver metastases | 100 |
Abbreviations: CRC, colorectal carcinoma; CRLM, CRC liver metastases; GOC, gastroesophageal carcinoma; PDO, patient-derived organoid.